Active Pharmaceutical Ingredients CDMO Market Size, Share & Trends Report

Active Pharmaceutical Ingredients CDMO Market Size, Share & Trends Analysis Report By Product (Highly Potent API, Antibody Drug Conjugate), By Synthesis, By Drugs, By Application, By Workflow, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Jun, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68038-282-2
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 100

Market Segmentation

  • Active Pharmaceutical Ingredient CDMO Product Outlook (Revenue, USD Million, 2016 - 2028)
    • Traditional Active Pharmaceutical Ingredient (Traditional API)
    • Highly Potent Active Pharmaceutical Ingredient (HP-API)
    • Antibody Drug Conjugate (ADC)
    • Others
  • Active Pharmaceutical Ingredient CDMO Synthesis Outlook (Revenue, USD Million, 2016 - 2028)
    • Synthetic
    • Biotech
  • Active Pharmaceutical Ingredient CDMO Drug Outlook (Revenue, USD Million, 2016 - 2028)
    • Innovative
    • Generics
  • Active Pharmaceutical Ingredient CDMO Application Outlook (Revenue, USD Million, 2016 - 2028)
    • Oncology
    • Hormonal
    • Glaucoma
    • Cardiovascular
    • Diabetes
    • Others
  • Active Pharmaceutical Ingredient CDMO Workflow Outlook (Revenue, USD Million, 2016 - 2028)
    • Clinical
    • Commercial
  • Active Pharmaceutical Ingredient CDMO Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
      • North America Active Pharmaceutical Ingredient CDMO Market, By Product
        • Traditional Active Pharmaceutical Ingredient (Traditional API)
        • Highly Potent Active Pharmaceutical Ingredient (HP-API)
        • Antibody Drug Conjugate (ADC)
        • Others
      • North America Active Pharmaceutical Ingredient CDMO Market, By Synthesis
        • Synthetic
        • Biotech
      • North America Active Pharmaceutical Ingredient CDMO Market, By Drug
        • Innovative
        • Generics
      • North America Active Pharmaceutical Ingredient CDMO Market, By Application
        • Oncology
        • Hormonal
        • Glaucoma
        • Cardiovascular
        • Diabetes
        • Others
      • North America Active Pharmaceutical Ingredient CDMO Market, By Workflow
        • Clinical
        • Commercial
      • U.S
        • U.S Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • U.S Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • U.S Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • U.S Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • U.S Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Canada
        • Canada Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Canada Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Canada Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Canada Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Canada Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
    • Europe
      • Europe Active Pharmaceutical Ingredient CDMO Market, By Product
        • Traditional Active Pharmaceutical Ingredient (Traditional API)
        • Highly Potent Active Pharmaceutical Ingredient (HP-API)
        • Antibody Drug Conjugate (ADC)
        • Others
      • Europe Active Pharmaceutical Ingredient CDMO Market, By Synthesis
        • Synthetic
        • Biotech
      • Europe Active Pharmaceutical Ingredient CDMO Market, By Drug
        • Innovative
        • Generics
      • Europe Active Pharmaceutical Ingredient CDMO Market, By Application
        • Oncology
        • Hormonal
        • Glaucoma
        • Cardiovascular
        • Diabetes
        • Others
      • Europe Active Pharmaceutical Ingredient CDMO Market, By Workflow
        • Clinical
        • Commercial
      • U.K.
        • U.K. Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • U.K. Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • U.K. Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • U.K. Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • U.K. Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Germany
        • Germany Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Germany Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Germany Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Germany Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Germany Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • France
        • France Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • France Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • France Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • France Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • France Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Italy
        • Italy Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Italy Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Italy Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Italy Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Italy Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Spain
        • Spain Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Spain Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Spain Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Spain Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Spain Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
    • Asia Pacific
      • Asia Pacific Active Pharmaceutical Ingredient CDMO Market, By Product
        • Traditional Active Pharmaceutical Ingredient (Traditional API)
        • Highly Potent Active Pharmaceutical Ingredient (HP-API)
        • Antibody Drug Conjugate (ADC)
        • Others
      • Asia Pacific Active Pharmaceutical Ingredient CDMO Market, By Synthesis
        • Synthetic
        • Biotech
      • Asia Pacific Active Pharmaceutical Ingredient CDMO Market, By Drug
        • Innovative
        • Generics
      • Asia Pacific Active Pharmaceutical Ingredient CDMO Market, By Application
        • Oncology
        • Hormonal
        • Glaucoma
        • Cardiovascular
        • Diabetes
        • Others
      • Asia Pacific Active Pharmaceutical Ingredient CDMO Market, By Workflow
        • Clinical
        • Commercial
      • Japan
        • Japan Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Japan Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Japan Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Japan Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Japan Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • China
        • China Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • China Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • China Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • China Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • China Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • India
        • India Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • India Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • India Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • India Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • India Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Australia
        • Australia Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Australia Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Australia Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Australia Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Australia Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • South Korea
        • South Korea Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • South Korea Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • South Korea Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • South Korea Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • South Korea Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
    • Latin America
      • Latin America Active Pharmaceutical Ingredient CDMO Market, By Product
        • Traditional Active Pharmaceutical Ingredient (Traditional API)
        • Highly Potent Active Pharmaceutical Ingredient (HP-API)
        • Antibody Drug Conjugate (ADC)
        • Others
      • Latin America Active Pharmaceutical Ingredient CDMO Market, By Synthesis
        • Synthetic
        • Biotech
      • Latin America Active Pharmaceutical Ingredient CDMO Market, By Drug
        • Innovative
        • Generics
      • Latin America Active Pharmaceutical Ingredient CDMO Market, By Application
        • Oncology
        • Hormonal
        • Glaucoma
        • Cardiovascular
        • Diabetes
        • Others
      • Latin America Active Pharmaceutical Ingredient CDMO Market, By Workflow
        • Clinical
        • Commercial
      • Brazil
        • Brazil Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Brazil Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Brazil Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Brazil Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Brazil Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Mexico
        • Mexico Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Mexico Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Mexico Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Mexico Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Mexico Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Argentina
        • Argentina Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Argentina Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Argentina Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Argentina Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Argentina Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Colombia
        • Colombia Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Colombia Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Colombia Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Colombia Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Colombia Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Chile
        • Chile Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Chile Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Chile Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Chile Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Chile Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
    • Middle East & Africa
      • Middle East & Africa Active Pharmaceutical Ingredient CDMO Market, By Product
        • Traditional Active Pharmaceutical Ingredient (Traditional API)
        • Highly Potent Active Pharmaceutical Ingredient (HP-API)
        • Antibody Drug Conjugate (ADC)
        • Others
      • Middle East & Africa Active Pharmaceutical Ingredient CDMO Market, By Synthesis
        • Synthetic
        • Biotech
      • Middle East & Africa Active Pharmaceutical Ingredient CDMO Market, By Drug
        • Innovative
        • Generics
      • Middle East & Africa Active Pharmaceutical Ingredient CDMO Market, By Application
        • Oncology
        • Hormonal
        • Glaucoma
        • Cardiovascular
        • Diabetes
        • Others
      • Middle East & Africa Active Pharmaceutical Ingredient CDMO Market, By Workflow
        • Clinical
        • Commercial
      • South Africa
        • South Africa Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • South Africa Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • South Africa Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • South Africa Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • South Africa Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • Saudi Arabia
        • Saudi Arabia Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • Saudi Arabia Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • Saudi Arabia Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • Saudi Arabia Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • Saudi Arabia Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial
      • UAE
        • UAE Active Pharmaceutical Ingredient CDMO Market, By Product
          • Traditional Active Pharmaceutical Ingredient (Traditional API)
          • Highly Potent Active Pharmaceutical Ingredient (HP-API)
          • Antibody Drug Conjugate (ADC)
          • Others
        • UAE Active Pharmaceutical Ingredient CDMO Market, By Synthesis
          • Synthetic
          • Biotech
        • UAE Active Pharmaceutical Ingredient CDMO Market, By Drug
          • Innovative
          • Generics
        • UAE Active Pharmaceutical Ingredient CDMO Market, By Application
          • Oncology
          • Hormonal
          • Glaucoma
          • Cardiovascular
          • Diabetes
          • Others
        • UAE Active Pharmaceutical Ingredient CDMO Market, By Workflow
          • Clinical
          • Commercial

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2016 to 2028
  • Market estimates and forecast for product segments up to 2028
  • Regional market size and forecast for product segments up to 2028
  • Market estimates and forecast for application segments up to 2028
  • Regional market size and forecast for application segments up to 2028
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.